EDGAR Filing Documents for 0001811764-22-000051

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001811764-22-000051

Filing Date

2022-05-13

Accepted

2022-05-13 08:18:31

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	a424b3and10-qcombined.htm	424B3	500013
2	EX-31.1	exhibit311-10qx03312022.htm	EX-31.1	11439
3	EX-31.2	exhibit312-10qx03312022.htm	EX-31.2	12182
4	EX-32	exhibit32-10qx03312022.htm	EX-32	8935
5		point-logoxcolour1a.jpg	GRAPHIC	17537
	Complete submission text file	0001811764-22-000051.txt		557881

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22920338
SIC: 2834 Pharmaceutical Preparations